Company Profiles

driven by the PitchBook Platform

Amakem

Description

Owner and operator of a bio-pharmaceutical company. The company develops therapeutics for the treatment of bowels, lungs disease and serious eye conditions.

2010

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$1.86M

Latest Deal Amount

$27.9M

Total Amount Raised

Description

Owner and operator of a bio-pharmaceutical company. The company develops therapeutics for the treatment of bowels, lungs disease and serious eye conditions.

Website:

www.amakem.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

BioVille Agoralaan building A bis 3590 DiepenbeekBelgium +32 (0)1 128 69 82
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Amakem's full profile, request a free trial.

    Amakem Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Amakem Investors (9)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    DevgenCorporationMinority000 0000000 0000
    Forbion Capital PartnersVenture CapitalMinority000 0000000 0000
    IWT.BEOther000 0000000 0000
    Life Sciences Research PartnersNot-For-Profit Venture CapitalMinority000 0000000 0000
    LRMVenture CapitalMinority000 0000000 0000
    Devgen Corporation
    Forbion Capital Partners Venture Capital
    IWT.BE Other
    Life Sciences Research Partners Not-For-Profit Venture Capital
    LRM Venture Capital

    Amakem Executive Team (5)

    NameTitleBoard
    Seat
    Contact
    Info
    Olivier Defert Ph.DCo-Founder & Director of Preclinical Product Development
    Dirk LeysenCo-Founder, Owner and Board Member
    Kieran Rooney Ph.DVice President, Business Development
    Maarten GeffenVice President, CMC and Operations
    Jean Marie StassenVice President, Research and Development
    Olivier Defert Ph.D Co-Founder & Director of Preclinical Product Development
    Dirk Leysen Co-Founder, Owner and Board Member
    Kieran Rooney Ph.D Vice President, Business Development
    Maarten Geffen Vice President, CMC and Operations
    Jean Marie Stassen Vice President, Research and Development

    Amakem Board Members (6)

    NameRepresentingRoleSinceContact
    Info
    Barbara Leyman Ph.DLRM CAPITALHead of Health and Care000 0000
    Dirk LeysenAmakemCo-Founder, Owner and Board Member000 0000
    Emmanuelle Coutanceau Ph.DOmnes CapitalInvestment Manager, Life Sciences000 0000
    Gaston Matthyssens Ph.DVesalius Biocapital PartnersManaging Partner000 0000
    Michael Palfreyman Ph.DAmakemChairman000 0000
    Barbara Leyman Ph.D Head of Health and Care LRM CAPITAL
    Dirk Leysen Co-Founder, Owner and Board Member Amakem
    Emmanuelle Coutanceau Ph.D Investment Manager, Life Sciences Omnes Capital
    Gaston Matthyssens Ph.D Managing Partner Vesalius Biocapital Partners
    Michael Palfreyman Ph.D Chairman Amakem
    Request full access to PitchBook